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ABSTRACT
Objectives: To explore access to primary healthcare
and drug therapy by refugee children in the East
Midlands region of England.
Design: Interviews with refugees with children and a
control group of British parents with children.
Setting: East Midlands region of England.
Participants: 50 refugees with children and a control
group of 50 parents with children.
Main outcome measures: Number of medicines
used by children in the last month and the past
6 months. Health of parents and children. Registration
with a general practitioner (GP).
Results: All families in both groups were registered
with a GP. There was no difference in the number of
children in the two groups experiencing illnesses .In
the last month, 30 refugee children received 60
medicines and 31 control children 63 medicines. In the
past 6 months, 48 refugee children received 108
medicines and 43 control children 96 medicines. There
was no difference between the two groups of children
in relation to the likelihood of receiving any medicines
in either the last month (P=0.839) or the past
6 months (p=0.81). Children in the refugee group were
more likely to receive prescribed medicines for the last
month (p=0.008) and the past 6 months (p<0.001).
They were also less likely to receive over the counter
(OTC) medicines in the past 6 months (p=0.009).
Conclusions: The refugee children in this study in the
East Midlands had access to primary healthcare,
medicines and a family doctor. They were more likely
to receive prescribed medicines and less likely to
receive OTC medicines, especially paracetamol.
INTRODUCTION
The right to access healthcare is included in
the Universal Declaration of Human Rights
by the United Nations.1 Children have the
right to access healthcare and receive medi-
cines that are scientiﬁcally evaluated for efﬁ-
cacy and safety.2 3 Research has mainly
focused on clinical trials that have evaluated
efﬁcacy. Access is an area that has been inad-
equately explored.4 Problems with access to
healthcare and medicines are well recognised
in low and lower middle income countries.
The lack of free universal healthcare in many
countries results in people being unable to
afford consultations with health professionals,
unnecessary investigations and medical treat-
ment.1 5 Only one in four children with diar-
rhoea in India receive treatment with oral
rehydration salts.1 6 Recent research in North
America has revealed that in the USA and
Canada, children of different ethnic groups
or without insurance may be less likely to
receive medicines.7–10
Refugee children are a highly vulnerable
group of children who are less likely to
receive full access to medicines and health-
care.11 Adult refugees are likely to experi-
ence signiﬁcant problems in accessing
healthcare and medical treatment.11–13 In
the UK, all refugees are entitled to access
primary healthcare, which includes register-
ing with a general practitioner (GP).14
However, concern has been raised that both
refugees and health professionals are con-
fused about what is available and refugees
may not register with a GP because they are
unaware that they have that right.14 15
There have been relatively few studies
looking at access to healthcare for refugee chil-
dren in the UK and to date there have been
no studies in the UK on whether these chil-
dren receive satisfactory drug therapy. We have
used the term ‘refugees’ to include both those
who have been awarded refugee status and
those seeking asylum. The aim was to explore
access to healthcare and drug therapy in this
vulnerable group of children.
Strengths and limitations of this study
▪ Study in refugee children—a vulnerable group.
▪ The number of medicines used by children as a
marker of access to primary healthcare.
▪ The refugee families all had contact with a
charity dealing with refugees.
Alkahtani S, et al. BMJ Open 2014;4:e006421. doi:10.1136/bmjopen-2014-006421 1
Open Access Research
group.bmj.com on December 19, 2014 - Published by http://bmjopen.bmj.com/Downloaded from 
METHODS
Initial contact with both asylum seekers and refugees
was made by Refugee Action (Nottingham branch). All
refugees attending a Refugee Action appointment were
asked if they had children and if they would be inter-
ested in participating in the research. Those parents,
who Refugee Action staff identiﬁed as possibly being
interested in participating in the research, were
approached by the research investigators (SA and JC).
Parents who then agreed to take part in the study were
interviewed within a private room in the ofﬁces provided
by Refugee Action in Nottingham. Written informed
consent was obtained. If the participants did not speak/
understand English/Arabic, then an interpreting service
was used. Additional interviews were performed at a
refugee drop in centre and a Muslim community centre
in Derby, by one of the researchers (SA). Again refugees
were asked if they had children and if they would be
interested in participating in the research. The interview
involved collecting the following data, using a question-
naire (see online supplementary appendix 1).
A. Demographic data regarding age and number of
children.
B. Data regarding health of the family, children, regis-
tration with the GP and immunisation status of the
children.
C. Whether any of the children had been ill in the last
month and if they had received any medicines, if so,
from whom.
D. Similar questions regarding illness and number of
medicines for the past 6 months.
The interviews were performed between November
2010 and November 2011.
A control group of parents were obtained in a local
shopping centre. The investigators wore University
t-shirts and ID badges and were provided with a quiet
area with seating within the shopping centre. Adults in
the shopping centre were approached by the investiga-
tors and asked two questions: (1) Did they have chil-
dren? (2) Were they British? If they answered yes to both
questions and written informed consent was given, the
interview was performed within the quiet seated area.
Interviews with the control group of parents were per-
formed between November 2011 and January 2012.
Interviews took 10–20 min and the same questions were
asked as for the refugee group.
Statistical analysis was performed by using the
Mann-Whitney test for demographic data. The χ2 test was
used to compare the proportion of children with illness,
and the proportion of children receiving medicines
(both prescribed and over the counter (OTC)). It was
not possible to perform a power calculation to determine
the sample size as there was insufﬁcient information avail-
able regarding the number of medicines used by children
in the UK. It was therefore decided to aim for 50 parents
in each group. This was a pragmatic decision based on
discussions with Refugee Action. The research was per-
formed as a pilot study in order to test the feasibility of
parents recalling such information and in order to obtain
pharmacoepidemiological data that would be useful for
power calculations for subsequent national studies.
RESULTS
Sixty-six parents of children who were refugees/asylum
seekers were invited to participate. Sixteen declined
(reasons not given for declining), that is, 50 agreed to par-
ticipate. Thirty-eight of the 50 parents who agreed to par-
ticipate were men. Most refugees were from Iraq (20),
Pakistan (6), Afghanistan (4) and Nigeria (4). There were
one to two refugees from each of the following countries
—Ethiopia, Somalia, Zimbabwe (all two); Gambia, Iran,
Tunisia, East Africa, Kenya, Sudan, Zambia, Vietnam (all
one). Two refugees did not state their country of origin.
The median age of the parents was 36 years (range 24–
58 years) and all were born outside the UK. They had
lived in the UK for a median of 6.25 years. Eighteen had
been awarded refugee status. One parent had been
refused refugee status and was lodging an appeal. The
remaining 31 were seeking asylum but their cases had not
been heard as yet. Eighteen parents reported that they
had a chronic illness (four chronic back pain, four depres-
sion, two diabetes, two disabilities and six other illnesses).
Eighteen parents were employed, 5 did not state their
occupation and 27 were unemployed (table 1).
The control group consisted of 50 parents of whom 44
were women. Twenty-one parents declined to participate
in the study. Their ages ranged from 19 to 46 years with
a median age of 34.5 years. Most of the parents were ﬁt
and well but ﬁve reported health problems (three
asthma and two depression/stress). Twenty-six of the
control parents were employed. As expected, the control
group of parents had lived in the current locality for a
longer period (17.5 vs 4.75 median years). Refugee
parents were more likely to have health problems.
Access to healthcare and medicines
All families were registered with a GP. There was no sig-
niﬁcant difference in the number of days since the last
visit to the GP (14 vs 15 days, refugees vs control). All
but one of the refugee parents and all but ﬁve of the
control group families had visited the GP in the past
6 months.
Table 1 Sociodemographics of parents
Refugee Control p Value
Median age (years) 36 34.5 0.12
Male 38 6 <0.001
Ill health 18 5 0.002
Employed 18 26 0.24
Number of years in current
accommodation
2.3 7.4 <0.001
Number of years in current
locality
4.8 17.5 <0.001
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There was a signiﬁcant difference (p=0.008) in that
nine of the refugee parents stated that they had experi-
enced difﬁculties visiting the GP in relation to affording
the travel costs and language problems. None of the
control group parents stated they had any difﬁculties.
Children’s health
There were 117 children in the refugee group and 99 in
the control group. The median number of children per
family was two in both groups (p=0.22). The median
ages of the children were 5 and 4 years, respectively
(refugees vs control). The IQRs for ages of the children
were 2.25–8 and 1.9–8 years, respectively, in the two
groups and there was no signiﬁcant difference in the
ages (p=0.13). All but one child in the refugee group
were immunised. Four children in the refugee group
had chronic medical problems (congenital heart
disease, asthma, cancer and poor growth). Seven chil-
dren in the control group had chronic medical pro-
blems (asthma (4), epilepsy, attention deﬁcit
hyperactivity disorder (ADHD) and arthritis).
There were 29 refugee families and 30 control families
with an ill child in the last month. In the last month 30
refugee children received 60 medicines and 31 control
children received 63 medicines (table 2). Paracetamol
was the most frequently used medicine in both groups.
The majority of the medicines for refugee children were
prescribed (41 out of 60). In contrast, the majority of
medicines for control children were OTC medicines
(37 out of 63).
In the past 6 months, all 50 refugee families and 45
control families had an ill child. In the past 6 months,
48 refugee children received 108 medicines and 43
control children received 96 medicines (table 3).
Paracetamol was the most frequently used medicine in
both groups. The majority of the medicines for refugee
children were prescribed (83 out of 108). In contrast,
the majority of the medicines for control children were
OTC medicines (52 out of 96).
There was no difference between the two groups of
children in relation to the likelihood of receiving any
medicines in either the last month (p=0.839) or the past
6 months (p=0.81). Children in the refugee group were
more likely to receive prescribed medicines for both the
last month (p=0.008) and the past 6 months (p<0.001).
They were also less likely to receive OTC medicines in
the past 6 months (p=0.009). Analgesics/antipyretics
were the most frequently used medicines in the last
month and the past 6 months (tables 2 and 3).
DISCUSSION
Based on the answers given by the parents, child refu-
gees were similar to the control group of children in
relation to the presence of chronic medical problems
and immunisation status. The main aim of this study was
to compare the number of medicines used by refugee
children in comparison with control children. It was
reassuring to see that the total number of medicines
used by both groups of children in the past month and
the past 6 months was similar. Alongside the fact that all
families were registered with a GP suggests that refugee
parents in this study were managing to access primary
healthcare and ensure that their children receive
adequate treatment. This is despite the difﬁculties in
travel costs and language noted by refugee parents.
Refugee children were, however, less likely to receive
OTC medicines and more likely to receive prescribed
medicines than control children.
A study in Dutch adolescents demonstrated that a
higher socioeconomic status was associated with an
increase in OTC drug use.16 Similar ﬁndings were
reported in German children and adolescents.17 A study
in the UK identiﬁed that the cost of OTCs affected only
the most deprived sections of the population.18 Refugees
Table 2 Medicines used in the last month
Medicines
Refugee Control
Prescribed OTC Total Prescribed OTC Total
Paracetamol 20 2 22 10 14 24
Ibuprofen 2 0 2 2 6 8
Antibiotics 7 0 7 6 0 6
Inhalers 3 0 3 5 0 5
Cough suppressants 1 2 3 3 1 4
Topical 0 0 0 0 1 1
Vitamins 1 2 3 0 10 10
Teething medicines 0 0 0 0 3 3
Lactulose 2 0 2 0 0 0
Honey 0 8 8 0 0 0
Herbal 0 4 4 0 1 1
Others 3 1 4 0 1 1
Unknown 2 0 2 0 0 0
Total 41 19 60 26 37 63
OTC, over the counter.
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face considerable ﬁnancial difﬁculties in that asylum
seekers are not allowed to work and receive signiﬁcantly
less ﬁnancial assistance than others on welfare bene-
ﬁts.19 Analgaesics/antipyretics are the most frequently
purchased OTC medicines by parents for children in
the UK.18 The two most common reasons for buying
OTC medicines by British parents included: (1) not
wishing to bother a GP for minor illness and (2) to have
a medicine in case of future need.18 It is likely that the
lower OTC use in refugee children is related to the
ﬁnancial cost of OTC medicines.
Parental recall of medicines administered to children
over a 12-month period has been used by researchers in
the UK and Australia.20 21 We used two time periods––1
and 6 months in our pilot study. Parental recall for the
last month is likely to be more accurate than for the
6 months. We were uncertain however whether a period
of 1 month would generate enough data in relation to
the number of medicines given. Based on our pilot
study, we would recommend asking about a time period
of 1 month only. We have showed that research in rela-
tion to access to medicine in refugee children is feasible
by working in conjunction with Refugee Action. We have
held discussions with other health professionals in the
UK in order to plan larger studies. The data generated
by our study will be used for the power calculations for
these larger studies.
Adult refugees were more likely to have health problems
than the control parents in this study. This is in keeping
with previous studies as refugees often come from coun-
tries affected by armed conﬂict and are likely to have
experienced bereavement, displacement or torture.19 It is
important to recognise that there are many differences in
refugees worldwide and that the health problems of refu-
gees from the Middle East in the UK are likely to be differ-
ent to those of South-East Asian refugees in Canada.22
There have been very few studies looking at access to
healthcare by refugee children.23 24 Additionally, there
have been no previous studies speciﬁcally looking at the
pharmacoepidemiology of medicines received by
refugee children. Our small study shows that it is pos-
sible to use both the number of medicines used by chil-
dren over the last month or the past 6 months as a
marker of access to healthcare. It is important to recog-
nise the limitations of our study. First, most of the refu-
gees interviewed had been in contact with Refugee
Action. These were refugees who had made contact with
a charity and were therefore fully informed of their
rights, especially with regard to healthcare.
Unfortunately, due to government cutbacks, the
Nottingham ofﬁce of Refugee Action has now closed
down and the nearest Refugee Action ofﬁce is in
Leicester, which is 40 km away. From April 2014 Refugee
Action no longer has a grant agreement with the Home
Ofﬁce to provide advice and support (formally One
Stop Shop) to individuals and families going through
the asylum system. This work is now provided through
another agency: Migrant Help. Migrant Help services
are split into Asylum Support Applications UK and
Asylum Advice UK and are provided across the UK
mainly through a national telephone service with some
limited outreach (for the East Midlands in Derby,
Nottingham and Leicester 1 day/week, respectively).
Refugee Action continue to provide a national Assisted
Voluntary Returns project; Choices. A project for vulner-
able destitute women in Leicester; Fresh Start and a vol-
unteer run project for vulnerable people; Prevention of
Asylum Homelessness which helps people to appeal
refusals of support under s4 of the Immigration and
Asylum Act 1999.
It is also likely that if we had looked at a different
group of children, for example, refugee children
Table 3 Medicines used in the past 6 months
Medicines
Refugee Control
Prescribed OTC Total Prescribed OTC Total
Paracetamol 39 4 43 19 23 42
Ibuprofen 2 0 2 2 10 12
Antibiotics 10 0 10 10 0 10
Inhalers 4 0 4 5 0 5
Cough suppressants 6 2 8 4 2 6
Topical 8 0 8 2 1 3
Vitamins 2 2 4 0 10 10
Teething medicines 0 1 1 0 4 4
Lactulose 2 0 2 0 0 0
Oral rehydration 1 0 1 2 1 3
Honey 0 8 8 0 0 0
Herbal 0 5 5 0 1 1
Others 2 3 5 0 0 0
Unknown 4 0 4 0 0 0
Iron 3 0 3 0 0 0
Total 83 25 108 44 52 96
OTC, over the counter.
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presenting to the emergency department, our ﬁndings
may have been different. A small study in Ireland of 25
refugees found that 20% of refugees were not registered
with a GP.15 Additionally, we did not look at the access to
healthcare and medicines of refugee children held in
immigration detention centres. Others have highlighted
that these children experience signiﬁcant health pro-
blems.25 It was not possible to match controls and
refugee parents by socioeconomic status. This is impos-
sible in the UK as asylum seekers receive less ﬁnancial
support than others on welfare beneﬁt.19 Another limita-
tion was the gender inbalance between refugees and
controls.
It is important to recognise that the number of people
seeking refugee status in the UK is actually quite low
(less than 20 000 in 2011).26 In May 2014, the
Immigration Act received Royal Assent. One of the aims
of the Act was to restrict access to public services and
people entering the UK illegally.27 It is uncertain
whether this includes people who have been refused
asylum. It is likely that in the future refugee children in
the UK will experience more difﬁculties in accessing
both healthcare and medicines.
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